• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

jason.roberts@unimelb.edu.au

Credentials


Position
Honorary (Senior Fellow)
Department of Infectious Diseases
ORCID

0000-0001-6218-435X

Dr Jason Roberts

Honorary (Senior Fellow)
Department of Infectious Diseases

914 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
    DOI: 10.1038/s41541-025-01355-y
  • 2026

    Journal article

    Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
    DOI: 10.1186/s13054-026-06075-w
  • 2026

    Journal article

    Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review
    DOI: 10.1186/s13054-026-05999-7
  • 2026

    Journal article

    Population Pharmacokinetics of Total and Free Ceftriaxone in Critically Ill and Non-Critically Ill Hospitalised Adult Patients
    DOI: 10.1016/j.ijantimicag.2026.107817
  • 2026

    Journal article

    Population pharmacokinetics of polymyxin B in critically ill patients with multi–drug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections
    DOI: 10.1016/j.ijantimicag.2026.107816
  • 2026

    Journal article

    The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrations
    DOI: 10.1093/jac/dkag189
  • 2026

    Journal article

    A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patients.
    DOI: 10.1128/aac.00372-26
Jason Roberts

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Defining Optimal Sampling Strategies for Cefepime Model-Informed Precision Dosing.
    DOI: 10.1097/FTD.0000000000001483
  • 2026

    Journal article

    Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept study.
    DOI: 10.1128/aac.01377-25
  • 2026

    Journal article

    Challenges and drivers in the implementation of current practices in outpatient parenteral antimicrobial therapy: an international survey
    DOI: 10.1093/jacamr/dlag095

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224